Denali Therapeutics Inc. (DNLI)
NASDAQ·Healthcare·Biotechnology
$23.97
+9.30%
Mkt Cap $3.34B
Analyst Ratings
Buy
14
Hold
0
Sell
0
Price Target (16 analysts)
$34.50
Range $25.00 – $40.00
Implied Upside
+43.9%
Consensus $34.50 vs current $23.97
NASDAQ·Healthcare·Biotechnology
$23.97
+9.30%
Mkt Cap $3.34B
Buy
14
Hold
0
Sell
0
Price Target (16 analysts)
$34.50
Range $25.00 – $40.00
+43.9%
Consensus $34.50 vs current $23.97